Clinical prediction of pathological complete response in breast cancer: a machine learning study.

Journal: BMC cancer
Published Date:

Abstract

BACKGROUND: This study aimed to develop and validate machine learning models to predict pathological complete response (pCR) after neoadjuvant therapy in patients with breast cancer patients.

Authors

  • Chongwu He
    Department of Breast Surgery, Jiangxi Cancer Hospital&Institute,Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang 330029, Jiangxi Province, China (C.H., X.Z., T.Y.).
  • Tenghua Yu
    Department of Breast Surgery, Jiangxi Cancer Hospital&Institute,Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang 330029, Jiangxi Province, China (C.H., X.Z., T.Y.). Electronic address: tengyeyu2024@163.com.
  • Liu Yang
    Department of Ultrasound, Hunan Children's Hospital, Changsha, China.
  • Longbo He
    Department of Breast Surgery, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, China.
  • Jin Zhu
    Department of Laboratory, Quzhou People's Hospital, Quzhou, Zhejiang, China, qzhosp@163.com.
  • Jing Chen
    Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.